Avinger, Anna M.
Sibold, Hannah Claire
Campbell, Gavin
Abernethy, Eli
Bourgeois, John
McClary, Tekiah
Blee, Shannon
Dixon, Margie
Harvey, R. Donald
Pentz, Rebecca D.
Funding for this research was provided by:
National Cancer Institute’s National Institutes of Health (P30CA138292)
National Cancer Institute's National Institutes of Health (P50CA217691-01A1)
Article History
Received: 7 June 2022
Accepted: 31 January 2023
First Online: 19 February 2023
Declarations
:
: This study was approved by the Protocol Review and Monitoring Committee and Institutional Review Board at Emory University Winship Cancer Institute (Study IDs: IRB00112187 for Windows and IRB00114961 for FIH). All methods were performed in accordance with the relevant guidelines and regulations for research with human subjects, including the Declaration of Helsinki. Following the instructions of our IRB, each patient was given an information sheet, which was also explained in detail. As approved by the Emory University IRB, consent was documented by the completion of the interview. This is in accord with United States regulations under the U.S. Department of Health and Human Services regulation 45 CFR 46. All personal information was de-identified. This study was only conducted in the United States.
: Not applicable.
: The authors declare that they have no competing interests.